Literature DB >> 10459553

Apolipoprotein E genotype and exercise training-induced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men.

J M Hagberg1, R E Ferrell, L I Katzel, D R Dengel, J D Sorkin, A P Goldberg.   

Abstract

We determined if the apolipoprotein E (APO E) genotype affects the exercise training-induced increase in plasma high-density lipoprotein cholesterol (HDL-C) and HDL2-C. Sedentary overweight men on an American Heart Association (AHA) step I diet had plasma lipoprotein-lipids measured before and after 9 months of endurance exercise training. APO E2 (n = 6), E3 (n = 33), and E4 (n = 12) groups were similar at baseline in terms of age, body weight and composition, and plasma lipoprotein-lipid profiles. APO E2 men had a larger increase in plasma HDL-C and HDL2-C with exercise training than APO E3 and E4 men (HDL-C, 8 +/- 4 v 3 +/- 1 v 2 +/- 1 mg/dL; HDL2-C, 5 +/- 3 v 1 +/- 1 v -1 +/- 1 mg/dL; mean +/- SE, all P < .01). After adjusting for body weight changes, the increases in plasma HDL-C and HDL2-C remained greater in APO E2 versus E3 and E4 men (all P < .03). These results indicate that APO E2 men may have greater plasma HDL-C and HDL2-C increases with endurance exercise training.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459553     DOI: 10.1016/s0026-0495(99)90185-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

Review 1.  Strength training in the elderly: effects on risk factors for age-related diseases.

Authors:  B F Hurley; S M Roth
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

Review 2.  Genetics, the environment, and lipid abnormalities.

Authors:  Jose M Ordovas; And Haiqing Shen
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 3.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 4.  Consensus statement on management of dyslipidemia in Indian subjects.

Authors:  K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal:  Indian Heart J       Date:  2014-12-24

5.  Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities.

Authors:  Richard L Seip; Robert F Zoeller; Theodore J Angelopoulos; James Salonia; Cherie Bilbie; Niall M Moyna; Mary P Miles; Paul S Visich; Linda S Pescatello; Paul M Gordon; Gregory J Tsongalis; Linda Bausserman; Paul D Thompson
Journal:  J Appl Physiol (1985)       Date:  2011-01-20

Review 6.  Physical activity and its effects on lipids.

Authors:  Philippe O Szapary; LeAnne T Bloedon; Gary D Foster
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

7.  Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease.

Authors:  Robyn A Honea; George P Thomas; Amith Harsha; Heather S Anderson; Joseph E Donnelly; William M Brooks; Jeffrey M Burns
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

8.  Genotype-phenotype associations: modulation by diet and obesity.

Authors:  Jose M Ordovas
Journal:  Obesity (Silver Spring)       Date:  2008-12       Impact factor: 5.002

9.  APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training.

Authors:  Thomas O Obisesan; Robert E Ferrell; Andrew P Goldberg; Dana A Phares; Tina J Ellis; James M Hagberg
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

10.  Similarity of polygenic profiles limits the potential for elite human physical performance.

Authors:  Alun G Williams; Jonathan P Folland
Journal:  J Physiol       Date:  2007-09-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.